Combined Structure- and Ligand-Based Approach for the Identification of Inhibitors of AcrAB-TolC in <i>Escherichia coli</i>-Reference-Cited by-同舟云学术

Combined Structure- and Ligand-Based Approach for the Identification of Inhibitors of AcrAB-TolC in Escherichia coli

Published:2023-10-27 Issue:12 Volume:9 Page:2504-2522
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Pisoni Lily A.¹²,Semple Susan J.²^ORCID,Liu Sida¹,Sykes Matthew J.¹^ORCID,Venter Henrietta¹^ORCID

Affiliation:

1. Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia 5000, Australia

2. Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia 5000, Australia

Funder

National Health and Medical Research Council

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.3c00350

Reference88 articles.

1. The Fight Against Antimicrobial Resistance Is Confounded by a Global Increase in Antibiotic Usage

2. Antibiotics in the clinical pipeline in October 2019

3. Reversing resistance to counter antimicrobial resistance in the World Health Organisation’s critical priority of most dangerous pathogens

4. World Health Organization. Antimicrobial Resistance Global Report on Surveillance World Heath Organisation; World Health Organization, 2014. https://apps.who.int/iris/handle/10665/112642. (accessed 10 July 2023).

5. O’Neill, J. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance, 2014. Accessed online at https://wellcomecollection.org/works/rdpck35v. (accessed 10 July 2023).